IHN Database

My favourite Supplements

Breast cancer and electromagnetic radiation

SEATTLE, WASHINGTON. Several studies have found a correlation between low nighttime melatonin levels and the risk of breast cancer. It is believed that low melatonin levels stimulate the pineal gland to call for the production of more estrogen, a significant risk factor for breast cancer. Researchers at the Fred Hutchinson Cancer Research Institute now report that nighttime exposure to electromagnetic fields commonly found in the home (60 Hz) can suppress melatonin production. The study involved 200 women aged 20 to 74 years with no history of breast cancer. The women participated in two 72-hour trials over a span of 6 to 12 months (to include the variable of seasonal change in the number of hours of darkness). The researchers measured the levels of light and electromagnetic radiation in the women's bedrooms during the night, tested urine samples for the level of 6-sulfatoxymelatonin (the major metabolite of melatonin), and conducted interviews to determine alcohol usage, smoking status and use of medications.

The researchers conclude that exposure to higher magnetic fields during the night is associated with a significant decrease in melatonin production. Melatonin production was also highly dependent on the number of hours of darkness (the more dark hours the more melatonin is produced). Increasing age and alcohol consumption was also associated with reduced melatonin production as was the use of certain classes of medications (beta-blockers, calcium channel blockers and psychotropics). NOTE: This study was partially funded by the Electric Power Research Institute.
Davis, Scott, et al. Residential magnetic fields, light-at-night, and nocturnal urinary 6-sulfatoxymelatonin concentration in women. American Journal of Epidemiology, Vol. 154, October 1, 2001, pp. 591-600

category search
Keyword Search

My favourite Supplements

copyright notice